NCT05384587 · Interventional trial
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Overall registry status Active not recruiting
Phase 2
Conditions Chronic Myelogenous Leukemia - Chronic Phase
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory